Tandem Diabetes Care (TNDM) Equity Ratio (2016 - 2025)
Tandem Diabetes Care's Equity Ratio history spans 13 years, with the latest figure at 0.18 for Q4 2025.
- For Q4 2025, Equity Ratio fell 35.23% year-over-year to 0.18; the TTM value through Dec 2025 reached 0.18, down 35.23%, while the annual FY2025 figure was 0.18, 35.23% down from the prior year.
- Equity Ratio reached 0.18 in Q4 2025 per TNDM's latest filing, up from 0.15 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.48 in Q4 2021 to a low of 0.15 in Q3 2025.
- Average Equity Ratio over 5 years is 0.33, with a median of 0.34 recorded in 2023.
- Peak YoY movement for Equity Ratio: grew 3.68% in 2022, then plummeted 38.99% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.48 in 2021, then decreased by 12.67% to 0.42 in 2022, then dropped by 21.22% to 0.33 in 2023, then dropped by 17.41% to 0.27 in 2024, then crashed by 35.23% to 0.18 in 2025.
- Per Business Quant, the three most recent readings for TNDM's Equity Ratio are 0.18 (Q4 2025), 0.15 (Q3 2025), and 0.15 (Q2 2025).